10x Genomics and Fred Hutchinson Cancer Center have launched a multi-project collaboration to study single cell and spatial profiling for cancer diagnostics, including biomarkers in bladder cancer and residual disease detection in AML.
OGT's SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
An AI-based solution may help predict various genetic features based on microscopic images of bone marrow smears to improve AML diagnosis.
Research shows benefits of screening patients in remission from acute myeloid leukemia for residual disease prior to a bone marrow transplant.
Read More
Identifying recurrent genetic alterations in myeloid neoplasms has improved diagnosis and expanded targeted treatments available to patients.
Read More
Alercell has launched a new website—Lena Diagnostics—dedicated to proprietary tests focused on early detection of cancer and leukemia.
Read More
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read More
Scientists are using new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24 million people globally.
Read More
CAR-T cell therapy has revolutionized the treatment of several cancers, using modified T cells to target types of leukemia & lymphoma.
Read More
Everyone has a small number of an unusual thymocyte cell, which can become a form of leukemia called T-cell acute lymphoblastic leukemia.
Read More
Kinetic River has been awarded a Phase II SBIR grant for the development of an autofluorescence-free flow cytometry platform.
Read More
To better treat patients with acute myeloid leukemia, researchers discovered a novel subtype of the cancer via proteome and genetic analysis.
Read More
Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia to inform more effective treatment strategies.
Read More
BioFluidica, a privately held biotechnology company, plans to commercialize its LiquidScan Automated Liquid Biopsy System.Â
Read More
The grant will allow Qlucore to expand Qlucore Diagnostics software with a focus on RNA-profiling of glioma and acute leukemia.
Read More
PixCell’s HemoScreen may be used to monitor pathological blood samples, improving treatment process for hematological patients.
Read More
The blood test followed by PET-CT imaging was 99.6% specific for cancer.
Read More
A noninvasive blood test may provide a ‘crystal ball’ for early detection of infections, leading to increased cure rates among pediatric leukemia patients.
Read More